Cargando…
Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma
Background: Up frameshift protein 1 (UPF1) is a key component of nonsense-mediated mRNA decay (NMD) of mRNA containing premature termination codons (PTCs). The dysregulation of UPF1 has been reported in various cancers. However, the expression profile of UPF1 and its clinical significance in clear c...
Autores principales: | Wu, Chun, Li, Hongmu, Chang, Wuguang, Zhong, Leqi, Zhang, Lin, Wen, Zhesheng, Mai, Shijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690017/ https://www.ncbi.nlm.nih.gov/pubmed/36421841 http://dx.doi.org/10.3390/genes13112166 |
Ejemplares similares
-
PD1(hi) CD200(hi) CD4(+) exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
por: Wu, Chun, et al.
Publicado: (2023) -
Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022) -
Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
por: Li, Hongmu, et al.
Publicado: (2023) -
Development of a copper metabolism-related gene signature in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022) -
Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
por: Wang, Jiawei, et al.
Publicado: (2023)